TOP NEWS: Astra Sells Hypertension Drugs; Drug Testing Hits Targets Read More
LONDON MARKET PRE-OPEN: AstraZeneca Sells Rights To Hypertension Drugs Read More
AbbVie Agrees Gastrointestinal Asset Sales Amid Allergan Merger Read More
AstraZeneca Launches USD1 Billion "Ambition Zero Carbon" Strategy Read More
UK BROKER RATINGS SUMMARY: Berenberg Downgrades Unilever To Hold Read More
US Grants AstraZeneca's Lynparza Priority Review For Prostate Cancer Read More
UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight Read More
TOP NEWS: Astra Ends Epanova Trial; Lynparza Gets US Priority Review Read More
LONDON BRIEFING: AstraZeneca To Take Hit After Epanova Trial Halted Read More
UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons Read More
TOP NEWS: Astra's Lokelma Approved In China, Farxiga Gets FDA Review Read More
LONDON MARKET PRE-OPEN: AstraZeneca Gets Positive News In US And China Read More
TOP NEWS: Astra, Merck & Co's Lynparza Approved For Cancer Treatment Read More
LONDON MARKET PRE-OPEN: Astra's Lynparza Approved; Rio Restarts RBM Read More
AstraZeneca's Triple-Combination Therapy Approved In China Read More
US FDA Approves AstraZeneca Breast Cancer Treatment Enhertu Read More
LONDON MARKET MIDDAY: Stocks Mixed Ahead Of Johnson's Brexit Deal Vote Read More
LONDON MARKET OPEN: Shell Dips After Warning Over Earnings Hit Read More
AstraZeneca Sells Two Cancer Drug Rights For Up To USD198 Million Read More
LONDON MARKET PRE-OPEN: AstraZeneca Sells Cancer Drug Rights Read More
